Related Experiment Video
Updated: Jun 8, 2026
07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Anxiety and depression in the elderly: do we know any more?
Gerard J Byrne1, Nancy A Pachana
1School of Medicine, University of Queensland, Mental Health Service, Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia. gerald.byrne@uq.edu.au
Current Opinion in Psychiatry
|September 11, 2010
Summary
Research on late-life depression is robust, but more studies on anxiety in older adults are urgently needed. Understanding the links between depression, cognitive decline, and dementia is crucial for geriatric mental health.
Area of Science:
- Geriatric Psychiatry
- Mental Health in Aging Populations
- Epidemiology of Mental Disorders
Background:
- Global population aging necessitates a focus on mental health challenges in older adults.
- High prevalence of mental disorders, particularly anxiety and depression, impacts quality of life in the elderly.
Purpose of the Study:
- To review recent scientific literature on anxiety and depression in older populations.
- To identify current research gaps and future directions in geriatric mental health.
Main Methods:
- Systematic review of recently published scientific articles.
- Analysis of findings related to prevalence, risk factors, and treatment of anxiety and depression in the elderly.
Main Results:
- Limited research exists on anxiety in older adults, despite growing interest indicated by new assessment scales.
- Depression in older adults is increasingly linked to cognitive decline and dementia, suggesting a bidirectional relationship.
- Obesity and depression exhibit a bidirectional relationship; treatment outcomes for late-life depression depend on cognitive function and white matter integrity.
Conclusions:
- While research on depression in older adults is mature, further investigation into pharmacological and non-pharmacological treatments is required.
- Urgent research is needed for anxiety disorders in older people due to their high prevalence and significant disease burden.
- Increased clinical and research focus on anxiety in the elderly is warranted as the literature on depression matures.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Stress and Mental Health
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...